NL-OMON25443尚未招募不适用
The cow’s milk protein allergy risk reducing effect of a partially hydrolyzed infant formula: Multicenter, Placebo-Controlled trial
Dr. Rouzha Pancheva, Prof. Dr. Paraskev Stoyanov Medical University of Varna, 55 Marin Drinov Str., 9002 Varna, BulgariaDr Nicolaos Nicolaou, Asthma and Allergy Center LTD, 24 Nafpliou Street, St Raphael Court, 2nd floor, No. 21, 3025, Limassol, CyprusDr. Nicoletta Iacovidou, Magginio Maternity Clinic, Aretaieio Hospital”, Athens, Greece0 个研究点目标入组 750 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 750
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Gestational age ≥37 weeks
- •Younger than 5 days (with regard to time to decide on participation)
排除标准
- •Severe acquired or congenital diseases, mental or physical disorders, symptoms of allergy according to the SCORAD or ComiSS forms
- •Gestational age <37 weeks
研究者
相似试验
尚未招募
不适用
Partial hydrolyzed protein in cows milk protein allergy risk reduction.Cow's milk allergy, infants with CMA riskNL-OMON24148aboratorios PiSa, MexicoIMSS Pachuca, Hidalgo, Mexico200
已完成
不适用
Immunological changes in children with cow's milk allergymilk allergymilkfoodallergyTCTR20190627001no60
招募中
不适用
CAMEL.NL-OMON28739Friesland Foods200
已完成
不适用
Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk AllergyCow's Milk AllergyNCT02379598Federico II University50
已完成
不适用
The effects of milk components intake on symptoms associated with menstruation.JPRN-UMIN000032530Meiji Co., Ltd.100